These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22040284)

  • 1. Effect on the production of soluble endoglin from human choriocarcinoma cells by preeclampsia sera.
    Aoki Y; Yamamoto T; Fumihisa C; Nakamura A; Asanuma A; Suzuki M
    Am J Reprod Immunol; 2012 May; 67(5):413-20. PubMed ID: 22040284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies isolated from patients with preeclampsia induce soluble endoglin production from trophoblast cells via interactions with angiotensin II type 1 receptor.
    Kobayashi Y; Yamamoto T; Chishima F; Takahashi H; Suzuki M
    Am J Reprod Immunol; 2015 Apr; 73(4):285-91. PubMed ID: 25376533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
    Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ
    Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of placenta growth factor, soluble fms-like tyrosine kinase-1, metal-responsive transcription factor-1, heme oxygenase 1 and hypoxia inducible factor-1α mRNAs in pre-eclampsia placenta and the effect of pre-eclampsia sera on their expression of choriocarcinoma cells.
    Maebayashi Asanuma A; Yamamoto T; Azuma H; Kato E; Yamamoto N; Murase T; Chishima F; Suzuki M
    J Obstet Gynaecol Res; 2014 Oct; 40(10):2095-103. PubMed ID: 25132343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1.
    Cudmore MJ; Ahmad S; Sissaoui S; Ramma W; Ma B; Fujisawa T; Al-Ani B; Wang K; Cai M; Crispi F; Hewett PW; Gratacós E; Egginton S; Ahmed A
    Eur Heart J; 2012 May; 33(9):1150-8. PubMed ID: 21411816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells.
    Brownfoot FC; Hannan N; Onda K; Tong S; Kaitu'u-Lino T
    Placenta; 2014 Sep; 35(9):724-31. PubMed ID: 25043692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.
    Cudmore M; Ahmad S; Al-Ani B; Fujisawa T; Coxall H; Chudasama K; Devey LR; Wigmore SJ; Abbas A; Hewett PW; Ahmed A
    Circulation; 2007 Apr; 115(13):1789-97. PubMed ID: 17389265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
    Govender N; Naicker T; Rajakumar A; Moodley J
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications.
    Ahmed A
    Thromb Res; 2011 Feb; 127 Suppl 3():S72-5. PubMed ID: 21262447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble endoglin contributes to the pathogenesis of preeclampsia.
    Venkatesha S; Toporsian M; Lam C; Hanai J; Mammoto T; Kim YM; Bdolah Y; Lim KH; Yuan HT; Libermann TA; Stillman IE; Roberts D; D'Amore PA; Epstein FH; Sellke FW; Romero R; Sukhatme VP; Letarte M; Karumanchi SA
    Nat Med; 2006 Jun; 12(6):642-9. PubMed ID: 16751767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia.
    Baumann MU; Bersinger NA; Mohaupt MG; Raio L; Gerber S; Surbek DV
    Am J Obstet Gynecol; 2008 Sep; 199(3):266.e1-6. PubMed ID: 18771978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on p38 mitogen activated protein kinase in vascular endothelial cells dysfunction in preeclampsia].
    Luo X; Liu DD; Qi HB; Yao ZW
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):36-40. PubMed ID: 21429433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxysterol-induced soluble endoglin release and its involvement in hypertension.
    Valbuena-Diez AC; Blanco FJ; Oujo B; Langa C; Gonzalez-Nuñez M; Llano E; Pendas AM; Díaz M; Castrillo A; Lopez-Novoa JM; Bernabeu C
    Circulation; 2012 Nov; 126(22):2612-24. PubMed ID: 23110859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review: the enigmatic role of endoglin in the placenta.
    Gregory AL; Xu G; Sotov V; Letarte M
    Placenta; 2014 Feb; 35 Suppl():S93-9. PubMed ID: 24252708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsia.
    Zhou CC; Irani RA; Zhang Y; Blackwell SC; Mi T; Wen J; Shelat H; Geng YJ; Ramin SM; Kellems RE; Xia Y
    Circulation; 2010 Jan; 121(3):436-44. PubMed ID: 20065159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble endoglin for the prediction of preeclampsia in a high risk cohort.
    Maynard SE; Moore Simas TA; Bur L; Crawford SL; Solitro MJ; Meyer BA
    Hypertens Pregnancy; 2010; 29(3):330-41. PubMed ID: 20670156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset.
    Hirashima C; Ohkuchi A; Matsubara S; Suzuki H; Takahashi K; Usui R; Suzuki M
    Hypertens Res; 2008 Aug; 31(8):1541-8. PubMed ID: 18971528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria.
    Ohkuchi A; Hirashima C; Matsubara S; Suzuki H; Takahashi K; Usui R; Suzuki M
    Hypertens Pregnancy; 2009 Feb; 28(1):95-108. PubMed ID: 19165674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.
    Xu B; Thornton C; Tooher J; Ogle R; Lim S; Makris A; Hennessy A
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):839-42. PubMed ID: 19215236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble endoglin and transforming growth factor-beta1 in women who subsequently developed preeclampsia.
    Lim JH; Kim SY; Park SY; Lee MH; Yang JH; Kim MY; Chung JH; Lee SW; Ryu HM
    Prenat Diagn; 2009 May; 29(5):471-6. PubMed ID: 19253312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.